Instituto de Diagnóstico S.A. (SNSE:INDISA)

Market Cap	381.93B +16.0%
Revenue (ttm)	280.84B +14.4%
Net Income	13.91B +60.4%
EPS	94.74 +54.0%
Shares Out	153.43M
PE Ratio	26.28
Forward PE	n/a
Dividend	15.50 (0.62%)
Ex-Dividend Date	May 19, 2026

Volume	8,338
Open	2,495.40
Previous Close	2,505.00
Day's Range	2,482.40 - 2,495.40
52-Week Range	2,384.10 - 2,935.90
Beta	0.38
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 4, 2026

About Instituto de Diagnóstico

Instituto de Diagnóstico S.A. provides health services in Chile. It offers patient information and exams instruction, and online services; specialties services; and outpatient services including urgency, laboratory, imaging, vaccination, blood bank, outpatient procedures, and reproductive medicine unit. The company also provides hospitalization services, such as maternity, adult and pediatric hospitalization, adult critical patient unit, pavilion and surgical procedures, neonatology, and robotic surgery; and telemedicine services comprising onl...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1961
• Employees: 3,091
• Stock Exchange: Santiago Stock Exchange
• Ticker Symbol: INDISA

Financial Performance

In 2025, Instituto de Diagnóstico's revenue was 272.31 billion, an increase of 13.90% compared to the previous year's 239.07 billion. Earnings were 15.66 billion, an increase of 115.23%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 30, 2026

Data Sources Report a data error